These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2059396)
21. Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension. Hollenberg NK; Williams GH; Anderson R Arch Intern Med; 2000 May; 160(10):1477-83. PubMed ID: 10826461 [TBL] [Abstract][Full Text] [Related]
22. Aims of combination therapy--improved quality of life or better blood pressure control? Maclean D Drugs; 1988; 35 Suppl 4():16-21. PubMed ID: 3378514 [TBL] [Abstract][Full Text] [Related]
23. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [TBL] [Abstract][Full Text] [Related]
24. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension. Clamp M; Holmes B; Wilcox R J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646 [TBL] [Abstract][Full Text] [Related]
25. The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension. Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID Eur J Clin Pharmacol; 1988; 34(6):543-8. PubMed ID: 3049118 [TBL] [Abstract][Full Text] [Related]
26. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM; J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701 [TBL] [Abstract][Full Text] [Related]
27. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group. Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385 [TBL] [Abstract][Full Text] [Related]
28. Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system. Gavras I; Mulinari R; Gavras H; Higgins JT; Reeves RL; Zawada ET; Crook J; Halperin AK; Garrett B Am J Med; 1987 Dec; 83(6B):20-3. PubMed ID: 3332575 [TBL] [Abstract][Full Text] [Related]
30. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension]. Kraft K; Schiessl S; Vetter H Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880 [TBL] [Abstract][Full Text] [Related]
31. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368 [TBL] [Abstract][Full Text] [Related]
32. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience. Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574 [TBL] [Abstract][Full Text] [Related]
33. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine. Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660 [TBL] [Abstract][Full Text] [Related]
34. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension]. Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension. Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID Drugs; 1988; 35 Suppl 4():29-35. PubMed ID: 3288468 [TBL] [Abstract][Full Text] [Related]
36. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension. Kirby BJ; Kitchin NR Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of nifedipine gastrointestinal therapeutic system for treatment of hypertension: results of the MATH Trial. Krakoff LR J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S14-7. PubMed ID: 7692145 [TBL] [Abstract][Full Text] [Related]
38. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group. Bravo EL; Krakoff LR; Tuck ML; Friedman CP Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319 [TBL] [Abstract][Full Text] [Related]
39. Nifedipine and/or atenolol for mild to moderate hypertension: a general practice study. Maclean D; Heagerty AM Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():343. PubMed ID: 2487806 [No Abstract] [Full Text] [Related]
40. Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study. Park JB; Shin JH; Kim DS; Youn HJ; Park SW; Shim WJ; Park CG; Kim DW; Lee HY; Choi DJ; Rim SJ; Lee SY; Kim JH; Clin Ther; 2016 Apr; 38(4):832-42. PubMed ID: 26996246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]